MarketPeel
Insider Trading Intelligence
CK

Chad J. Kolean

CLRB
CHIEF FINANCIAL OFFICER · CELLECTAR BIOSCIENCES, INC. · CIK 0001616753
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$25.0K
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
5,000
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Chad J. Kolean, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+2.54%+0.58%+1.96%+1.96%
14d2+100.00%+6.55%+0.61%+5.95%+5.95%
30d2+0.00%-0.21%+0.20%-0.42%-0.42%
60d2+100.00%+2.96%+3.96%-1.00%-1.00%
90d2+100.00%+18.39%+7.37%+11.02%+11.02%
180d2+0.00%-45.88%+10.86%-56.74%-56.74%
1y2+0.00%-41.23%+20.20%-61.42%-61.42%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLRB · 5,000 shares · as of Jul 2, 2025
072,500145,000217,500290,000202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 8 buys / 0 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASE
Chief Financial Officer
5,000$4.99$24.9K6,418Jul 2, 2025Jul 3, 2025View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASE
Chief Financial Officer
5,000$0.01$505,000Jul 2, 2025Jul 3, 2025View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
290,000290,000Feb 14, 2025Feb 18, 2025View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
290,000290,000Jun 14, 2024Jun 18, 2024View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
42,55442,578Dec 8, 2023Dec 12, 2023View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
104,000104,000Jun 23, 2023Dec 12, 2023View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
104,000104,000Jan 17, 2023Jan 18, 2023View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 22, 2022Feb 24, 2022View →
Other insiders · CLRB
Loading peer insiders…
About this filer
CIK 0001616753
ROLE
Chief Financial Officer
PRIMARY
CLRB
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001616753DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback